Quidel Corporation is recalling approximately 135,440 units of the InflammaDry MMP-9 Test because the test result windows are misaligned. This defect can cause the positive test line to be hidden under the plastic cassette, making it impossible for a user to see a positive result. This manufacturing error affects two specific product versions (REF: PRS-ID-20-U and PRS-ID-20) distributed across 44 U.S. states and several international locations. Consumers should contact their healthcare provider or the manufacturer regarding affected units.
A misaligned test line can be hidden behind the device's plastic casing, causing a user to receive a false negative result when they are actually positive for MMP-9. This could lead to a delay in diagnosis or improper treatment for inflammatory eye conditions.
Manufacturer notification
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.